You have 9 free searches left this month | for more free features.

omalizumab

Showing 1 - 25 of 106

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Spontaneous Urticaria Trial (Remibrutinib, Placebo to remibrutinib, Placebo to omalizumab)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • (no location specified)
Sep 20, 2023

Allergic Asthma Trial (omalizumab, )

Completed
  • Allergic Asthma
  • omalizumab
  • placebo
  • (no location specified)
Dec 9, 2022

Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)

Recruiting
  • Asthma in Children
  • +2 more
  • Omalizumab
  • Placebo
  • Washington, District of Columbia
    Children's National Hospital
Aug 26, 2022

Food Allergy Trial in Odense C (Omalizumab, Placebo)

Recruiting
  • Food Allergy
  • Omalizumab
  • Placebo
  • Odense C, Funen, Denmark
    Odense Research Center for Anaphylaxis, Allergy Center, Odense U
Sep 20, 2022

Omalizumab in Children With Allergic Asthma.

Completed
  • Allergic Asthma
  • Omalizumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

Not yet recruiting
  • Nasal Polyps
  • Omalizumab
  • SNOT22 score
  • Shiraz, Fars, Iran, Islamic Republic of
    Imam Reza Allergy and Immunology clinic, Shiraz University of Me
May 31, 2022

XOLAIR Outcomes in Pediatric Allergic Asthma United States

Completed
  • Asthma
  • Omalizumab
  • East Hanover, New Jersey
    Novartis Investigational Site
Dec 15, 2021

Asthma Trial in Shanghai (Omalizumab)

Completed
  • Asthma
  • Omalizumab
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Oct 8, 2021

Chronic Urticaria, Idiopathic Trial in Aurora (Omalizumab)

Recruiting
  • Chronic Urticaria, Idiopathic
  • Omalizumab
  • Aurora, Colorado
    University of Colorado Anschutz
Mar 23, 2022

Peanut Allergy, Food Allergy Trial in United States (Omalizumab, )

Active, not recruiting
  • Peanut Allergy
  • Food Allergy
  • Omalizumab
  • placebo
  • Stanford, California
  • +3 more
Jan 11, 2022

Moderate-to-severe Allergic Asthma Trial in United States (Omalizumab)

Terminated
  • Moderate-to-severe Allergic Asthma
  • Omalizumab
  • Rolling Hills Estates, California
  • +11 more
Feb 16, 2022

Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

Active, not recruiting
  • Asthma
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Oct 23, 2022

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Korea, Republic of (YH35324, Placebo, Omalizumab)

Completed
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Suwon-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jan 26, 2023

Idiopathic Angioedema Trial in Madison (Omalizumab, Placebos)

Completed
  • Idiopathic Angioedema
  • Omalizumab
  • Placebos
  • Madison, Wisconsin
    UW Madison
Oct 21, 2021

Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

Recruiting
  • Allergic Disease
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Jul 24, 2023

Seasonal Allergic Rhinitis Trial in Beijing (Omalizumab)

Completed
  • Seasonal Allergic Rhinitis
  • Omalizumab
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Jan 26, 2021

Allergic Bronchopulmonary Aspergillosis Trial (Prednisone tablet, itraconazole, Omalizumab)

Not yet recruiting
  • Allergic Bronchopulmonary Aspergillosis
  • Prednisone tablet
  • +2 more
  • (no location specified)
Nov 19, 2021

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Seongnam-si, Suwon-si, Seoul (YH35324, Placebo,

Recruiting
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Nov 11, 2022

Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial in Worldwide (Dupilumab, Omalizumab, Placebo)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Asthma
  • Tucson, Arizona
  • +65 more
Jul 12, 2022

Asthma, Allergic Rhinitis, Atopic Dermatitis Trial in Sacramento (Omalizumab, Placebo)

Completed
  • Asthma
  • +2 more
  • Omalizumab
  • Placebo
  • Sacramento, California
    UC Davis Department of Dermatology
Jun 21, 2021

Chronic Urticaria Trial in Denver (Omalizumab)

Completed
  • Chronic Urticaria
  • Omalizumab
  • Denver, Colorado
    University of Colorado Hospital
Nov 10, 2020

Symptomatic Dermographism Trial in Freiburg, Mainz (Omalizumab, Placebo)

Completed
  • Symptomatic Dermographism
  • Omalizumab
  • Placebo
  • Freiburg, Germany
  • +1 more
Oct 9, 2020

Urticaria Chronic Trial in Baltimore (Omalizumab)

Completed
  • Urticaria Chronic
  • Omalizumab
  • Baltimore, Maryland
    Johns Hopkins Asthma and Allergy Center
May 20, 2021

Asthma, Eosinophilic Asthma Trial in New Lambton (Mepolizumab, Omalizumab)

Unknown status
  • Asthma
  • Eosinophilic Asthma
  • New Lambton, New South Wales, Australia
    John Hunter Hospital
Oct 6, 2020

Asthma Trial in United States (Omalizumab, Placebo)

Recruiting
  • Asthma
  • Omalizumab
  • Placebo
  • Phoenix, Arizona
  • +12 more
Jan 13, 2022